65,437 trials
Crohn's Disease
Primary: Number of Participants Who Had the Mendel Mantoux Test as the First Screening Test for Active or Latent Tuberculosis (TB) Before Starting Treatment — 92; 53; 3…
Adenoids Hypertrophy
Primary: Change From Baseline in Adenoid/Choana (A/C) Index Grade — 0.3; 0.2; 0.4; 0.3 Score on a Scale
Hepatitis C
Primary: Number of Participants With Sustained Response (SR) at the End of the 6-month Follow-up Period — 23; 20; 21 participants
Non-Small-Cell Lung Carcinoma
Primary: Overall Objective Response Rate (ORR) — 11.7; 3.8 percentage of participants
Breast Cancer
Primary: Overall Survival — 399; 324 Days
Psoriasis
Primary: Number of Patients Experiencing One or More Adverse Events Occurring From Week 0 Through Week 12 — 149; 158 participants
Facial Wrinkles
Primary: Percentage of Subjects With Product-related Adverse Events. — 71; 72 percentage of subjects with AEs.
Acne Vulgaris
Primary: Number of Participants With Improvement of at Least 2 Grades in the Investigator's Static Global Assessment (ISGA) Score From Baseline to Week 12 — 129; 82; 100; 59…
Major Depressive Disorder
Primary: Change From Baseline in Hamilton Psychiatric Scale for Depression-17 Item (HAM-D17) Score — -4.76; -5.82 scores on a scale
Cancer
Primary: Mean (SD) Pharmacokinetic (PK) Parameter Area Under Concentration Time Curve From Zero to Infinity (AUC0-oo) — 600; 731; 720 ng*hr/mL
Type 2 Diabetes
Primary: Number of Participants Who Experienced at Least One Adverse Event — 3; 1; 1; 2 participants
Bronchiectasis
Primary: Change From Baseline in Total Bacterial Load in the Sputum at End of Treatment (Day 29). — -2.94; -0.32 log10 of CFU per gram sputum — p=< 0.001
Psoriasis
Primary: Number of Participants With a Target Lesion Global Improvement (TLGI) Score of 0, 1, or 2 at Weeks 1, 2, and 4 — 6; 2; 19; 3 participants — p=0.1269
HIV Infections
Primary: Change in Absolute CD4+ Lymphocyte Counts From Baseline (Average of Pre-entry and Entry Values) — 15; 11; 12; 8 cells/mm^3 — p=0.1996
Brain Diseases · Spinal Cord Diseases
Primary: Categorical Visualization Score (CVS) — 1.43; 2.02; 1.98 Scores on a scale — p=0.003